GRAFTSITE Trademark

Trademark Overview

On Thursday, February 7, 2019, a trademark application was filed for GRAFTSITE with the United States Patent and Trademark Office. The USPTO has given the GRAFTSITE trademark a serial number of 88292982. The federal status of this trademark filing is REGISTERED as of Tuesday, February 25, 2020. This trademark is owned by Summit Medical Limited. The GRAFTSITE trademark is filed in the Medical Instrument Products category with the following description:

medical tubing for administering drugs; drug delivery devices; drug infusion devices
graftsite

General Information

Serial Number88292982
Word MarkGRAFTSITE
Filing DateThursday, February 7, 2019
Status700 - REGISTERED
Status DateTuesday, February 25, 2020
Registration Number5998754
Registration DateTuesday, February 25, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkGRAFT SITE
Goods and Servicesmedical tubing for administering drugs; drug delivery devices; drug infusion devices

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, March 1, 2019
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSummit Medical Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGloucestershire GL542HQ
GB
Party NameSummit Medical Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGloucestershire GL542HQ
GB

Trademark Events

Event DateEvent Description
Monday, February 11, 2019NEW APPLICATION ENTERED
Friday, March 1, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 19, 2019ASSIGNED TO EXAMINER
Friday, April 19, 2019NON-FINAL ACTION WRITTEN
Friday, April 19, 2019NON-FINAL ACTION E-MAILED
Friday, April 19, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 1, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 1, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 1, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 2, 2019NON-FINAL ACTION WRITTEN
Tuesday, July 2, 2019NON-FINAL ACTION E-MAILED
Tuesday, July 2, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, December 27, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 15, 2020ASSIGNED TO LIE
Wednesday, January 15, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 15, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 23, 2020LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, February 25, 2020REGISTERED-SUPPLEMENTAL REGISTER
Tuesday, February 25, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, January 16, 2020APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

Related Keywords

graftsite devices drug delivery infusion drugs tubing administering medical